ScholarIQanswers from OpenAlex & ORCID
Kazuhito Shiosakai
ResearcherPublications, citations & collaboration network
Kazuhito Shiosakai is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kazuhito Shiosakai have?
ScholarIQindexed works
Kazuhito Shiosakai has 79 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kazuhito Shiosakai have?
ScholarIQcitation count
Kazuhito Shiosakai has 876 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kazuhito Shiosakai?
ScholarIQh-index
Kazuhito Shiosakai has an h-index of 18 in OpenAlex.
What is the i10-index of Kazuhito Shiosakai?
ScholarIQi10-index
Kazuhito Shiosakai has an i10-index of 35 in OpenAlex.
What is the OpenAlex record for Kazuhito Shiosakai?
ScholarIQopenalex
The OpenAlex for Kazuhito Shiosakai is on the source record.
What are the most-cited papers on Kazuhito Shiosakai?
ScholarIQmost cited works
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
Naoki Niikura, Takashi Yamanaka, Hironori Nomura, Kazuhiro Shiraishi, Hiroki Kusama, M. Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Shosuke Kita, Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, Shuji Sakai, Yoko Kiga, Tadahiro Izutani, Kazuhito Shiosakai, Junji Tsurutani
Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
Yu Nakamura, Shin Kitamura, Akira Homma, Kazuhito Shiosakai, Daiju Matsui
Combination of GSH Trapping and Time-Dependent Inhibition Assays as a Predictive Method of Drugs Generating Highly Reactive Metabolites
Shintaro Nakayama, Hideo Takakusa, Akiko Watanabe, Yoshihiro Miyaji, Wataru Suzuki, Daisuke Sugiyama, Kazuhito Shiosakai, Kokichi Honda, Noriko Okudaira, Takashi Izumi, Osamu Okazaki
Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study
Takuya Nikaido, Hiroshi Takatsuna, Shunsuke Tabata, Kazuhito Shiosakai, Taichi Nakatani, Shin‐ichi Konno
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
Sonoko Misawa, Tadamichi Denda, Sho Kodama, Takuji Suzuki, Yoichi Naito, Takahiro Kogawa, Mamoru Takada, Tomoki Suichi, Kazuhito Shiosakai, Satoshi Kuwabara, on behalf of the MiroCIP study group, Go Saito, Aoi Hino, Shunsuke Imanishi, Norio Ureshino, Daisuke Satomi, Yuko Tanabe, Yutaka Hanaoka, Atsushi Miyamoto, Takeshi Suzuki, Atsushi Naganuma, Yasuhiro Yanagita, Katsutoshi Sekine, Fumihiko Kusano, Masato Nakamura, Hiroshi Imazeki